A phase I study of pharmacokinetics of trastuzumab emtansine in Chinese patients with locally advanced inoperable or metastatic human epidermal growth factor receptor 2-positive breast cancer who have received prior trastuzumab-based therapy
一项针对既往接受过曲妥珠单抗治疗的局部晚期不可切除或转移性人表皮生长因子受体2阳性乳腺癌中国患者的曲妥珠单抗-美坦新药代动力学I期研究
期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000022886
Ji, Dongmei; Shen, Weina; Zhang, Jian; Cao, Junning; Li, Wenhua; Lam, Lisa H; Wu, Fan; Wang, Bei; Li, Zao; Sun, Guofang; Hu, Xichun; Chen, Shang-Chiung